RecruitingPhase 3NCT06381063

Non-steroidal Anti-inflammatory in Cardiac Surgery

Effect of Non-steroidal Anti-inflammatory Drugs in Pain Management After Cardiac Surgery


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

238 participants

Start Date

Mar 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Non-steroidal anti-inflammatory drugs (NSAID) are part the multimodal strategy in pain management after surgery. However, major concerns are raised in cardiac surgery given the potential side effects of NSAID with more bleeding and acute kidney injury. The investigators hypothesized that NSAID are safe in the early postoperative course after cardiac surgery with respect to contraindication.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called PLacebo, a drug called ketoprofen, and others for people with cardiac surgery, multimodal pain management, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGpain management

o Pain management in both arms Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day, patient control analgesia with morphine or oxycontin

DRUGketoprofen

Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration

DRUGPLacebo

Placebo twice a day, during 48 h after surgery, intravenous administration


Locations(1)

CHU Amiens Picardie

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06381063


Related Trials